Thomas Cusack - 08 Nov 2025 Form 4 Insider Report for HERON THERAPEUTICS, INC. /DE/ (HRTX)

Role
Director
Signature
/s/ Kathryn Lester Attorney-in-fact for Thomas P. Cusack
Issuer symbol
HRTX
Transactions as of
08 Nov 2025
Net transactions value
+$249,999
Form type
4
Filing time
12 Nov 2025, 09:20:31 UTC
Previous filing
07 Nov 2025
Next filing
03 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Cusack Thomas Director 100 REGENCY FOREST DRIVE, SUITE 300, CARY /s/ Kathryn Lester Attorney-in-fact for Thomas P. Cusack 12 Nov 2025 0002094824

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HRTX Common Stock Award +37,879 37,879 08 Nov 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRTX Stock Option (Right to Buy) Award $249,999 +227,272 $1.10 227,272 08 Nov 2025 Common Stock 227,272 $1.10 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were granted as restricted stock units which vest in 16 equal quarterly installments beginning one quarter after the date of grant.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 The stock options vest and become exercisable in 48 equal monthly installments beginning one month after the date of grant.